Newborn Screening (NBS)
Newborn screening (NBS) identifies potentially serious and life-threatening conditions within the first days of a newborn’s life. Most babies appear healthy and show no signs of illness right after birth. However, some infants may be born with certain disorders or inherited genetic conditions that can lead to disability or death. When detected early, many of these disorders can be managed and can prevent the occurrence of adverse health outcomes.
The Georgia Newborn Screening Program ensures that every newborn in Georgia has a blood screening, hearing screening, and critical congenital heart disease (CCHD) screening at birth to identify certain
conditions
which pose a threat of severe illness, physical or developmental disability, or death.
The Georgia Newborn Screening Program contracts with a network of medical systems and organizations to follow up with abnormal screening results.
- Emory University Newborn Screening Program
(Organic Acid Disorders, Fatty Acid Oxidation Disorders, Amino Acid Disorders, Lysosomal Storage Disorders, Endocrine Disorders, and Other Disorders) - Augusta University Sickle Cell Program
- Children’s Healthcare of Atlanta Sickle Cell Program
- Sickle Cell Foundation of Georgia
Newborn Screening Resources for Specific Audiences:


How to Request Newborn Screening Records:
Page last updated 6/10/2025